[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - The United States and Europe are in line to receive the first doses of an experimental coronavirus vaccine after a partnership between Pfizer and BioNTech yielded excellent preliminary results in a large-scale Subscribe to our Premium Membership Plan. Already Subscribed?